Key Financial Inc’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Key Financial Inc’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-475	Closed	-$1.22K	–	1226
2022 Q4	$1.22K	Hold	475	–	–	﹤0.01%	1009
2022 Q3	$1K	Buy	+475	New	+$1.18K	﹤0.01%	1101

Other funds holding PRTK

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Key Financial Inc's PRTK Position: Q1 2023 in Review

Key Financial Inc sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2023, closing a stake of 475 shares — an estimated $1.22K sold.

Key Financial Inc first reported a position in PRTK in Q3 2022 and held it in 2 quarters. The position peaked at $1.22K in Q4 2022. 63 funds tracked by Wall St. Rank hold PRTK as of Q1 2023.

Key Financial Inc reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Key Financial Inc sold 475 Paratek Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.22K.
Key Financial Inc first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
Key Financial Inc's Paratek Pharmaceuticals, Inc. position peaked at $1.22K in Q4 2022.
63 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2023.

Based on Key Financial Inc's 13F filing for Q1 2023, filed 2 May 2023.